• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与支气管扩张症恶化住院相关的因素:一项为期一年的随访研究。

Factors associated with hospitalization in bronchiectasis exacerbations: a one-year follow-up study.

机构信息

Pneumology Department, Hospital Universitario y Politécnico La Fe / Instituto de Investigación Sanitaria (IIS) La Fe. University of Valencia, Valencia, Spain.

Centro de Investigación Biomédica En Red-Enfermedades Respiratorias (CIBERES, CB06/06/0028), Madrid, Spain.

出版信息

Respir Res. 2017 Sep 30;18(1):176. doi: 10.1186/s12931-017-0659-x.

DOI:10.1186/s12931-017-0659-x
PMID:28964260
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5622554/
Abstract

BACKGROUND

Bronchiectasis (BE) is a chronic structural lung disease with frequent exacerbations, some of which require hospital admission though no clear associated factors have been identified. We aimed to evaluate factors associated with hospitalization due to exacerbations during a 1-year follow-up period.

METHODS

A prospective observational study was performed in patients recruited from specialized BE clinics. We considered all exacerbations diagnosed and treated with antibiotics during a follow-up period of 1 year. The protocol recorded baseline variables, usual treatments, Bronchiectasis Severity Index (BSI) and FACED scores, comorbid conditions and prior hospitalizations.

RESULTS

Two hundred and 65 patients were recruited, of whom 162 required hospital admission during the follow-up period. Independent risk factors for hospital admission were age, previous hospitalization due to BE, use of proton pump inhibitors, heart failure, FACED and BSI, whereas pneumococcal vaccination was a protective factor. The area under the receiver operator characteristic curve (AUC) was 0.799 for BSI model was 0.799, and 0.813 for FACED model.

CONCLUSIONS

Previous hospitalization, use of proton pump inhibitors, heart failure along with BSI or FACED scores is associated factors for developing exacerbations that require hospitalization. Pneumococcal vaccination was protective. This information may be useful for the design of preventive strategies and more intensive follow-up plans.

摘要

背景

支气管扩张症(BE)是一种慢性结构性肺病,常伴有加重,其中一些需要住院治疗,但尚未确定明确的相关因素。我们旨在评估在 1 年随访期间因加重而住院的相关因素。

方法

对来自专门的 BE 诊所招募的患者进行前瞻性观察性研究。我们考虑了在 1 年随访期间诊断和用抗生素治疗的所有加重。该方案记录了基线变量、常规治疗、支气管扩张严重指数(BSI)和 FACED 评分、合并症和既往住院情况。

结果

共招募了 206 名患者,其中 162 名患者在随访期间需要住院治疗。需要住院治疗的独立危险因素是年龄、既往因 BE 住院、质子泵抑制剂的使用、心力衰竭、FACED 和 BSI,而肺炎球菌疫苗接种是保护性因素。BSI 模型的受试者工作特征曲线下面积(AUC)为 0.799,FACED 模型的 AUC 为 0.813。

结论

既往住院、质子泵抑制剂的使用、心力衰竭以及 BSI 或 FACED 评分是需要住院治疗的加重的相关因素。肺炎球菌疫苗接种具有保护作用。这些信息可能对制定预防策略和更强化的随访计划有用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8347/5622554/ebb21dab8782/12931_2017_659_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8347/5622554/2ad3725a546d/12931_2017_659_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8347/5622554/ebb21dab8782/12931_2017_659_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8347/5622554/2ad3725a546d/12931_2017_659_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8347/5622554/ebb21dab8782/12931_2017_659_Fig2_HTML.jpg

相似文献

1
Factors associated with hospitalization in bronchiectasis exacerbations: a one-year follow-up study.与支气管扩张症恶化住院相关的因素:一项为期一年的随访研究。
Respir Res. 2017 Sep 30;18(1):176. doi: 10.1186/s12931-017-0659-x.
2
Prognostic utility of various multidimensional grading scales among Saudi patients with bronchiectasis.沙特支气管扩张症患者中各种多维分级量表的预后效用。
Respir Med Res. 2021 Nov;80:100843. doi: 10.1016/j.resmer.2021.100843. Epub 2021 Jun 7.
3
The bronchiectasis severity index. An international derivation and validation study.支气管扩张严重指数。一项国际推导和验证研究。
Am J Respir Crit Care Med. 2014 Mar 1;189(5):576-85. doi: 10.1164/rccm.201309-1575OC.
4
Performance of Multidimensional Severity Scoring Systems in Patients with Post-Tuberculosis Bronchiectasis.多维严重程度评分系统在肺结核后支气管扩张患者中的表现
Int J Chron Obstruct Pulmon Dis. 2020 Sep 14;15:2157-2165. doi: 10.2147/COPD.S261797. eCollection 2020.
5
Prognostic Value of Frequent Exacerbations in Bronchiectasis: The Relationship With Disease Severity.支气管扩张症频繁急性加重的预后价值:与疾病严重程度的关系
Arch Bronconeumol (Engl Ed). 2019 Feb;55(2):81-87. doi: 10.1016/j.arbres.2018.07.002. Epub 2018 Aug 16.
6
Multidimensional severity assessment in bronchiectasis: an analysis of seven European cohorts.支气管扩张症的多维严重程度评估:对七个欧洲队列的分析
Thorax. 2016 Dec;71(12):1110-1118. doi: 10.1136/thoraxjnl-2016-208481. Epub 2016 Aug 11.
7
Comparison of two prognostic scores (BSI and FACED) in a Spanish cohort of adult patients with bronchiectasis and improvement of the FACED predictive capacity for exacerbations.西班牙成年支气管扩张患者队列中两种预后评分(BSI和FACED)的比较以及FACED对病情加重预测能力的改善
PLoS One. 2017 Apr 6;12(4):e0175171. doi: 10.1371/journal.pone.0175171. eCollection 2017.
8
Predicting high risk of exacerbations in bronchiectasis: the E-FACED score.预测支气管扩张症急性加重的高风险:E-FACED评分
Int J Chron Obstruct Pulmon Dis. 2017 Jan 18;12:275-284. doi: 10.2147/COPD.S121943. eCollection 2017.
9
Predicting mortality in non-cystic fibrosis bronchiectasis patients using distance-saturation product.利用距离-饱和度乘积预测非囊性纤维化支气管扩张症患者的死亡率。
Ann Med. 2021 Dec;53(1):2034-2040. doi: 10.1080/07853890.2021.1999490.
10
Clinical characteristics and validation of bronchiectasis severity score systems for post-tuberculosis bronchiectasis.肺结核后支气管扩张严重程度评分系统的临床特征及验证
Clin Respir J. 2018 Aug;12(8):2346-2353. doi: 10.1111/crj.12911.

引用本文的文献

1
Clinical characteristics and risk factors analysis of allergic bronchopulmonary aspergillosis combined with bronchiectasis.变应性支气管肺曲霉病合并支气管扩张的临床特征及危险因素分析
Front Med (Lausanne). 2025 May 23;12:1557241. doi: 10.3389/fmed.2025.1557241. eCollection 2025.
2
Respiratory Pathology and Cardiovascular Diseases: A Scoping Review.呼吸病理学与心血管疾病:一项范围综述
Open Respir Arch. 2024 Nov 23;7(1):100392. doi: 10.1016/j.opresp.2024.100392. eCollection 2025 Jan-Mar.
3
The impact of cardiovascular events in bronchiectasis: a systematic review and meta-analysis.

本文引用的文献

1
Bronchiectasis and COPD Overlap: A Case of Mistaken Identity?支气管扩张症与慢性阻塞性肺疾病重叠:一例误诊病例?
Chest. 2017 Jun;151(6):1204-1206. doi: 10.1016/j.chest.2016.12.027.
2
Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research.成人支气管扩张症肺部加重:临床研究的共识定义。
Eur Respir J. 2017 Jun 8;49(6). doi: 10.1183/13993003.00051-2017. Print 2017 Jun.
3
Comparison of two prognostic scores (BSI and FACED) in a Spanish cohort of adult patients with bronchiectasis and improvement of the FACED predictive capacity for exacerbations.
支气管扩张症中心血管事件的影响:一项系统评价与荟萃分析。
ERJ Open Res. 2024 Sep 30;10(5). doi: 10.1183/23120541.01032-2023. eCollection 2024 Sep.
4
Systemic immune-inflammation index in predicting hospitalized bronchiectasis exacerbation risks and disease severity.全身免疫炎症指数在预测住院支气管扩张症加重风险和疾病严重程度方面的作用
J Thorac Dis. 2024 May 31;16(5):2767-2775. doi: 10.21037/jtd-23-1392. Epub 2024 May 8.
5
Effects of Probiotics on Clinical Manifestations of Bronchiectasis: A Randomized, Triple Blinded, Placebo-Controlled Clinical Trial.益生菌对支气管扩张症临床表现的影响:一项随机、三盲、安慰剂对照临床试验
Tanaffos. 2023 Feb;22(2):221-229.
6
COPD Assessment Test and risk of readmission in patients with bronchiectasis: a prospective cohort study.慢性阻塞性肺疾病评估测试与支气管扩张症患者再入院风险:一项前瞻性队列研究
ERJ Open Res. 2024 Mar 18;10(2). doi: 10.1183/23120541.00867-2023. eCollection 2024 Mar.
7
Pulmonary exacerbations in insured patients with bronchiectasis over 2 years.两年内参保支气管扩张症患者的肺部加重情况。
ERJ Open Res. 2023 Jul 3;9(4). doi: 10.1183/23120541.00021-2023. eCollection 2023 Jul.
8
Risk Factors for Influenza-Induced Exacerbations and Mortality in Non-Cystic Fibrosis Bronchiectasis.非囊性纤维化支气管扩张症患者流感诱发加重和死亡的危险因素。
Viruses. 2023 Feb 14;15(2):537. doi: 10.3390/v15020537.
9
Multimorbidity in bronchiectasis: a systematic scoping review.支气管扩张症中的多重疾病:一项系统的范围综述。
ERJ Open Res. 2023 Jan 16;9(1). doi: 10.1183/23120541.00296-2022. eCollection 2023 Jan.
10
Long-Term Domiciliary High-Flow Nasal Therapy in Patients with Bronchiectasis: A Preliminary Retrospective Observational Case-Control Study.支气管扩张症患者的长期家庭高流量鼻导管治疗:一项初步回顾性观察病例对照研究
J Clin Med. 2022 Dec 9;11(24):7323. doi: 10.3390/jcm11247323.
西班牙成年支气管扩张患者队列中两种预后评分(BSI和FACED)的比较以及FACED对病情加重预测能力的改善
PLoS One. 2017 Apr 6;12(4):e0175171. doi: 10.1371/journal.pone.0175171. eCollection 2017.
4
Patients hospitalized with an infective exacerbation of bronchiectasis unrelated to cystic fibrosis: Clinical, physiological and sputum characteristics.因非囊性纤维化相关性支气管扩张感染加重而住院的患者:临床、生理及痰液特征
Respirology. 2017 Jul;22(5):922-927. doi: 10.1111/resp.13005. Epub 2017 Feb 24.
5
Effectiveness of 23-valent pneumococcal polysaccharide vaccination in preventing community-acquired pneumonia hospitalization and severe outcomes in the elderly in Spain.23价肺炎球菌多糖疫苗在预防西班牙老年人社区获得性肺炎住院及严重后果方面的有效性。
PLoS One. 2017 Feb 10;12(2):e0171943. doi: 10.1371/journal.pone.0171943. eCollection 2017.
6
Predicting high risk of exacerbations in bronchiectasis: the E-FACED score.预测支气管扩张症急性加重的高风险:E-FACED评分
Int J Chron Obstruct Pulmon Dis. 2017 Jan 18;12:275-284. doi: 10.2147/COPD.S121943. eCollection 2017.
7
Etiology of Bronchiectasis in a Cohort of 2047 Patients. An Analysis of the Spanish Historical Bronchiectasis Registry.2047 例患者队列中支气管扩张症的病因。西班牙历史支气管扩张症登记处的分析。
Arch Bronconeumol. 2017 Jul;53(7):366-374. doi: 10.1016/j.arbres.2016.12.003. Epub 2017 Jan 21.
8
Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study.支气管扩张症患者的合并症与死亡率风险:一项国际多中心队列研究。
Lancet Respir Med. 2016 Dec;4(12):969-979. doi: 10.1016/S2213-2600(16)30320-4. Epub 2016 Nov 16.
9
The EMBARC European Bronchiectasis Registry: protocol for an international observational study.欧洲支气管扩张症登记研究(EMBARC):一项国际观察性研究方案
ERJ Open Res. 2016 Jan 20;2(1). doi: 10.1183/23120541.00081-2015. eCollection 2016 Jan.
10
Annual direct medical costs of bronchiectasis treatment: Impact of severity, exacerbations, chronic bronchial colonization and chronic obstructive pulmonary disease coexistence.支气管扩张症治疗的年度直接医疗费用:严重程度、急性加重、慢性支气管定植及慢性阻塞性肺疾病并存情况的影响
Chron Respir Dis. 2016 Nov;13(4):361-371. doi: 10.1177/1479972316643698. Epub 2016 Jul 7.